@article{article, title  = {{Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://eprints.whiterose.ac.uk/91088/ }},

 year = {{2016}},

 month = {{3}},

 author = {{Essat M and Tappenden P and Ren S and Bessey A and Archer R and Wong R and Lobo A and Hoque S}},

 doi = {{10.1007/s40273-015-0334-3}},

 volume = {{34}},

 journal = {{PharmacoEconomics}},

 issue = {{3}},

 pages = {{245-257}},

 note = {{Accessed on 2024/12/21}}}